Zhejiang Jolly Pharmaceutical 

¥13.60
0
+¥0.20+1.49% 07:04 今天

統計

當日最高
13.65
當日最低
13.43
52週高點
19.42
52週低點
12.3
成交量
10,256,062
平均成交量
20,802,069
市值
9.54B
本益比
36
股息殖利率
2.61%
股息
0.36

即將到來

股息

2.61%股息殖利率
May 26
¥0.35
May 25
¥0.60
May 24
¥0.45
May 23
¥0.30
May 22
¥0.20
10年成長
17.46%
5年成長
28.47%
3年成長
5.27%
1年成長
-41.67%

財報

28Aug預期
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Q2 2026
999
333
-333
-999
預期EPS
不適用
實際EPS
不適用

財務

19.99%利潤率
有盈利
2019
2020
2021
2022
2023
2024
5.08B營收
1.02B淨利

競爭對手

此清單為基於近期市場事件的分析。並非投資建議。

關於

Zhejiang Jolly Pharmaceutical Co., Ltd. is a Chinese enterprise dedicated to the research, manufacturing, and global distribution of traditional Chinese medicinal products. The company's diverse portfolio includes the Wuling capsule, prescribed for conditions such as insomnia, amnesia, heart palpitations, general fatigue, weakness in the lower back and legs, and tinnitus. This capsule also addresses energy deficiency and a weak pulse often linked to an imbalance of the heart and kidneys, or neurasthenia. Additionally, they produce the Lingze tablet, which targets frequent or painful urination, weak or continuous urine flow, and lower back and knee soreness, especially when these symptoms are associated with benign prostatic hyperplasia, kidney insufficiency, or blood stasis. Another offering, the Bailing tablet, serves as an adjunctive treatment for coughs, asthma, back pain, and chronic bronchitis stemming from lung and kidney deficiencies. The firm also markets Linglianhua particles, used to manage symptoms including excessive sweating, sleep disturbances, irritability, heart flutters, vivid dreams, dizziness with tinnitus, lower back and leg weakness, dry stools, an unusual tongue appearance, and a feeble pulse, often seen in perimenopausal syndrome or heart and kidney disharmony. Beyond these traditional Chinese medicine formulations, Zhejiang Jolly Pharmaceutical provides a range of injectable pharmaceuticals, such as azithromycin, clindamycin phosphate, doxapram, pefloxacin mesylate, adenosine cyclophosphate, and sodium nitroprusside. The company further supplies raw medicinal ingredients, including cordyceps cephalosporium, fermented cordyceps, and Wuling powders. Expanding its reach into healthcare services, Zhejiang Jolly Pharmaceutical Co., Ltd. invests in and participates with Deqing No.3 People's Hospital. Established in 2000 and based in Huzhou, China, the entity now known as Zhejiang Jolly Pharmaceutical Co., Ltd. adopted this name in 1998, evolving from its earlier designation, Zhejiang Jolly Pharmaceutical Health Products Co., LTD.
Show more...
執行長
Tao Wang
員工
2861
國家
中國
ISIN
CNE100001096

上市

0 Comments

分享你的想法

FAQ

Zhejiang Jolly Pharmaceutical 今天的股價是多少?
300181.SZ 目前價格為 ¥13.60 CNY,過去 24 小時上漲了 +1.49%。在圖表上更密切關注 Zhejiang Jolly Pharmaceutical 股價表現。
Zhejiang Jolly Pharmaceutical 的股票代號是什麼?
根據交易所不同,股票代號可能會有所差異。例如,在 Shenzhen Stock Exchange 交易所,Zhejiang Jolly Pharmaceutical 的股票以代號 300181.SZ 進行交易。
Zhejiang Jolly Pharmaceutical 的股價在上漲嗎?
300181.SZ 股票較上週下跌 -1.16%,本月下跌 -5.29%,過去一年 Zhejiang Jolly Pharmaceutical 下跌 -27.89%。
Zhejiang Jolly Pharmaceutical 的市值是多少?
今天 Zhejiang Jolly Pharmaceutical 的市值為 9.54B
Zhejiang Jolly Pharmaceutical 去年的營收是多少?
Zhejiang Jolly Pharmaceutical 去年的營收為 5.08BCNY。
Zhejiang Jolly Pharmaceutical 去年的淨利是多少?
300181.SZ 去年的淨收益為 1.02BCNY。
Zhejiang Jolly Pharmaceutical 會發放股息嗎?
是的,300181.SZ 的股息每 年度 發放一次。每股最新股息為 0.35 CNY。截至今日,股息殖利率(FWD)% 為 2.61%。
Zhejiang Jolly Pharmaceutical 有多少名員工?
截至 September 08, 2026,公司共有 2,861 名員工。
Zhejiang Jolly Pharmaceutical 位於哪個產業?
Zhejiang Jolly Pharmaceutical從事於Health & Wellness產業。
Zhejiang Jolly Pharmaceutical 何時完成拆股?
Zhejiang Jolly Pharmaceutical 上次拆股發生於 May 20, 2015,比例為 1.7:1。
Zhejiang Jolly Pharmaceutical 的總部在哪裡?
Zhejiang Jolly Pharmaceutical 的總部位於 中國 的 Huzhou。